JP2016028100A - Stable isotope-labeled collagen, and amino acid composition and peptide composition in which the collagen is dissolved - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a stable isotope-labeled collagen and the like which are highly substituted by a stable isotope-labeled amino acid.SOLUTION: A stable isotope-labeled collagen precursor, in which 90 mol% or more of at least one or more amino acids selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His composing collagen are substituted by corresponding stable isotope-labeled amino acids, is a stable isotope-labeled collagen which is subjected to post-translational modification, comprising one in which 90 mol% or more of Hyp is substituted by the corresponding stable isotope-labeled amino acids.SELECTED DRAWING: None

Description

  The present invention relates to a stable isotope-labeled collagen, and an amino acid composition and a peptide composition in which the collagen is decomposed.

  Collagen is an important constituent that accounts for about 30% of proteins in the body. It is known that nearly 30 types of collagen are distributed in a living body with a composition unique to each tissue, and the composition is changed depending on age, physiological conditions, diseases, and the like (Non-patent Document 1). Further, post-translationally modified amino acids specific to collagen include 3-hydroxypropylene (3Hyp), 4-hydroxypropylene (4Hyp), hydroxylysine (Hyl), galactosylhydrolysine (GHL), and glucosylhydroglycine (GHL). However, it has also been reported that the amount increases or decreases depending on tissues, diseases, and other conditions (Non-patent Document 1). Changes in collagen type composition in tissues and changes in the amount of post-translationally modified amino acids have been reported in various diseases such as cancer, fibrosis, osteoporosis, and osteogenesis imperfecta. Therefore, the significance of collagen measurement is increasing. For this reason, a method of separating 3Hyp and 4Hyp having very similar structures using a HILIC column and analyzing it by liquid chromatography / mass spectrometry (hereinafter referred to as LC / MS analysis) (Non-patent Document 2) A method of detecting and quantifying tissue-derived collagen by type by LC / MS analysis using tryptic digestion of type I to V collagen and then using a peptide specific to each type has been developed (Non-patent Document 3). In addition, as a method for measuring such collagen, there is also known a method for measuring collagen in which a monoclonal antibody against collagen is bound to collagen in a specimen and the collagen in the specimen is measured (Patent Document 1).

  On the other hand, a protein quantification method using a stable isotope-labeled peptide is also known (Patent Document 2). A step of decomposing a mixture of a protein to be quantified and a known amount of an artificial standard protein containing a plurality of evaluation peptides with a digestive enzyme, and a known amount of a peptide for evaluation of stable isotope labeling in a sample obtained in the step a And b step of performing mass spectrometry by adding a stable isotope-labeled peptide having the same sequence as the peptide that is the digest of the protein to be quantified, the amount of the added artificial standard protein and the quantitative value of each evaluation peptide, And a c step for calculating an evaluation value of pretreatment efficiency. The evaluation peptide has an amino acid sequence that does not coincide with a naturally occurring protein and variants thereof, has an amino acid sequence that can be detected by mass spectrometry, and is recognized by a protein digestion enzyme. By using this evaluation peptide, it is possible to evaluate the efficiency of pretreatment of an arbitrary measurement sample, and to ensure the reliability of the protein quantitative value.

  In addition, a peptide fragmentation treatment is performed on a mixture of a target protein and a stable isotope labeled protein corresponding to a specific amount of the labeled protein, mass spectrometry is performed on the obtained peptide fragment group, and a target protein-derived peptide fragment / The ratio of stable isotope-labeled protein-derived peptide fragments is quantified, and the average of the quantitative values of all the target protein-derived peptide fragments is obtained as the average quantitative value, and the difference between the average quantitative value and each target protein-derived peptide fragment is determined. There is a method of detecting it as a mass change (Patent Document 3). According to the method, post-translational modification of the target protein, sequence abnormality of the target protein due to gene mutation, splicing variant, mass change due to protein cleavage or degradation by protease, etc. can be analyzed.

JP-A-6-242109 JP 2010-197110 A International Publication No. 2012/11249

The collagens: biochemistry and pathology, 1992 Amino acid analysis by hydrophilic interaction chromatography coupled on-line to electrospray ionization mass spectrometry: Amino Acids, 30 (3), pp 291-2, pp 291-2 Identification of collagen types in tissues using HPLC-MS / MS: J Sep Sci, 31 (20), pp3483-3488, 2008 A novel functional role of collagen glycosylation interaction with the endoconic collagen receptor upap / ENDO180: J Biol Chem, 286 (37) -3, pp4827 Increased lysine hydroxylation in rat bone and tendon collagen and localization of the additional resources. M.M. Stoltz, H.M. Furthmayr, R.A. Timpl: Biochimica et. : Biophysica Acta, 310, pp461-468, 1973 Characteristic and Quantitative Determinating of the Hydrocyline-linked Carbohydrate Units of Universal Collagene. Robert G. Spiro: The Journal of Biological Chemistry Vol. 244, no. 3, pp602-612, 1969

  However, in the method using the antibody shown in Patent Document 1, it is not easy to perform type-specific analysis of collagen. This is because collagen has a repetitive sequence represented by Gly-XY when glycine is Gly and amino acids are X and Y, and thus a cross reaction between collagen types is likely to occur. In addition, as for collagen quantification by type including minor components and analysis of post-translational modification of collagen, it is difficult to analyze 3Hyp and 4Hyp, and to analyze trace amounts of 3Hyp, GHL, and GGHL.

  In addition, in the method based on mass spectrometry described in Non-Patent Document 2 and Non-Patent Document 3, the difference in ionization efficiency between samples due to the presence of contaminants, fluctuations in elution time in a HILIC column, etc. A measurement error of the derived quantitative value may occur. In particular, in the quantification of other types of collagen that are slightly mixed, and in the quantification of trace components such as 3Hyp, GHL, and GGHL, these errors greatly affect the measured values. Accurate quantitative analysis covering modifications is difficult.

  Furthermore, the method described in Patent Document 2 calculates the ratio with the mass of a peptide that is a digest of an artificial standard protein, based on a known amount of a peptide for stable isotope labeling evaluation, and treatment with a protein digestive enzyme It adds efficiency. In order to evaluate digestion efficiency, it is necessary to prepare four kinds of evaluation peptides that are the same sequence as the peptide that is a digest of the artificial standard protein and are labeled with stable isotopes. In Patent Document 2, the stable isotope-labeled peptide is synthesized by the F-moc method using leucine labeled with 6 pieces of 13C or the like, but it is not easy to produce a plurality of types in large quantities. In addition, the method described in Patent Document 2 determines that the pretreatment has been sufficiently performed when the evaluation rate is 0.8 or higher on average, that is, when the digestibility is 80% or higher on average even when any peptide is evaluated. However, it does not guarantee accurate quantification. Therefore, it is desired to develop a simple method for preparing stable isotope-labeled proteins and an accurate method for quantifying target proteins.

  In addition, in the methods described in Patent Document 2 and Patent Document 3, an artificial standard protein is synthesized by transforming a vector into which a cDNA of a target protein and a tag sequence are inserted into E. coli, but its preparation is not easy. For example, in Patent Document 3, a stable isotope-labeled tag protein fusion protein is used as an internal standard substance. And C. to which magnesium sulfate heptahydrate was added. H. O.I. D. After culturing until 600 nm becomes 0.7, an amino acid labeled with a stable isotope 15N is added to 0.5 g / L to induce nephrin expression. However, stable isotope-labeled nephrin is purified using a cobalt column and a glutathione column. Thus, the manufacturing method of an artificial standard protein is complicated, and development of the manufacturing method which can prepare a standard protein more simply is desired.

  In the methods described in Patent Document 2 and Patent Document 3, protein degradation is limited to enzymatic digestion. In Patent Document 3, peptides containing post-translationally modified amino acids are detected by LC / MS analysis, and post-translationally modified amino acids are detected. Is measuring. On the other hand, as a method for analyzing post-translationally modified amino acids, each post-translationally modified amino acid alone by amino acid hydrolysis has been conventionally analyzed. By using a stable isotope-labeled standard protein, it is possible to perform high-accuracy analysis that absorbs the effects of hydrolysis efficiency and ionization efficiency at the time of analysis, as in the case of enzymatic degradation. In addition, the method for producing a stable isotope-labeled standard protein is complicated, and at the same time, even if the target protein is purified using a His tag or the like, it is difficult to obtain the target protein with high purity without any other protein. It is. If there are contaminating proteins, specific detection and quantification using peptides derived from the target protein is possible by enzyme treatment, but when amino acid hydrolysis is performed, it is not possible to know which protein each post-translational modification originates from Therefore, accurate quantitative analysis is not achieved. Therefore, development of a production method capable of preparing a stable isotope-labeled standard protein with higher purity is desired.

  Moreover, since the method of patent document 2 and patent document 3 makes the degradation efficiency by the enzyme of a measurement object protein and an internal standard substance into a problem, protein degradation is limited to enzyme digestion. Since other than peptides cannot be detected, Patent Document 3 detects peptides containing post-translationally modified amino acids by LC / MS analysis and measures post-translationally modified amino acids. For this reason, when the position of the amino acid subjected to post-translational modification in the measurement target amino acid is unknown or the position varies, the post-translational modified amino acid cannot be quantified. Therefore, it is desired to develop a highly accurate analysis method using a stable isotope-labeled standard protein that can be analyzed in amino acid units.

  In view of the above situation, an object of the present invention is to provide a stable isotope-labeled collagen having a high substitution rate with a stable isotope-labeled amino acid, and an amino acid composition and a peptide composition in which the collagen is decomposed.

  As a result of detailed studies on a method for analyzing collagen using LC / MS analysis in order to solve the above-mentioned problems, the present inventors have obtained a high purity in which a specific amino acid is substituted by 90 mol% or more with a corresponding stable isotope-labeled amino acid. By using stable isotope-labeled collagen as an internal standard substance, amino acids can be accurately quantified by hydrolyzates with acids and alkalis, regardless of enzymatic degradation, and stable isotope-labeled Pro and stable isotopes can be used as stable isotope-labeled amino acids. When using the body-labeled Lys, the compounding ratio of these amino acids and these post-translationally modified amino acids can be accurately quantified, and further, the amino acid per collagen can be quantified by converting the stable isotope-labeled Arg as an index. As a result, the present invention has been completed. In addition, stable isotope-labeled collagen can be easily produced by using cultured cells.

That is, the present invention relates to a stable isotope-labeled amino acid (hereinafter referred to as at least one amino acid selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His constituting collagen). Stable isotope-labeled collagen (hereinafter referred to as labeled collagen) obtained by post-translational modification of a stable isotope-labeled collagen precursor (hereinafter also referred to as labeled collagen precursor) substituted by 90 mol% or more with a labeled amino acid. A method for analyzing collagen, which is also referred to as
A mixture of the labeled collagen and the target collagen or collagen-derived amino acid or peptide component is used as a measurement sample,
The collagen-derived peptide component, or a peptide obtained by degrading the measurement target collagen as a measurement target peptide, the mass of the measurement target peptide and the measurement target peptide corresponding to the measurement target peptide obtained by degrading the labeled collagen A peptide mass ratio measuring step for measuring a mass ratio with the mass of the labeled collagen-derived peptide, and / or an amino acid obtained by degrading the collagen-derived amino acid or the collagen to be measured as a measurement target amino acid, An amino acid mass ratio measurement step of measuring a mass ratio of the mass and the mass of the amino acid derived from the labeled collagen corresponding to the measurement target amino acid obtained by decomposing the labeled collagen, and the following (i) to ( iv)
(I) quantifying the amount of collagen to be measured contained in the measurement sample from the mass ratio of the amino acids and the amount of stable isotope-labeled collagen added to the measurement sample;
(Ii) quantifying the amount of amino acids constituting the collagen to be measured from the mass ratio of the amino acids and the amount of amino acids derived from the stable isotope-labeled collagen added to the measurement sample;
(Iii) quantifying the type-specific collagen amount of the collagen to be measured from the mass ratio of the peptide and the stable isotope-labeled collagen amount added to the measurement sample;
(Iv) Quantifying the collagen-derived component to be measured using a calibration curve of the mass ratio of the amino acid or the peptide prepared in advance,
The present invention provides a method for analyzing collagen, comprising any of the quantitative steps described above.

  Further, the present invention provides a labeled amino acid corresponding to at least one amino acid selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His, which constitutes collagen. The substituted labeled collagen precursor is a post-translationally modified labeled collagen.

  In the present invention, the labeled collagen precursor is obtained by replacing at least 90 mol% of Pro, Lys, and Arg with the corresponding labeled amino acid; Hyp is 90 mol% with the corresponding labeled amino acid. The above-described labeled collagen, which is substituted as described above, and the above-mentioned labeled collagen which is 95 mol% or more are provided.

  Furthermore, the present invention provides an amino acid composition or a peptide composition in which the labeled collagen is decomposed.

  According to the present invention, using labeled collagen, the labeled collagen and the measurement target collagen are decomposed, and the amount of post-translationally modified amino acid derived from the measurement target collagen contained in the measurement sample, the amount of peptide, and the total measurement target collagen amount, In addition, the type of collagen to be measured can be quantified.

  In this invention, since the amino acid and peptide obtained by decomposing | disassembling collagen can be analyzed by LC / MS, the mass ratio of a peptide and the mass ratio of an amino acid can be handled in parallel.

  The present invention also provides labeled collagen-derived amino acid compositions and peptide compositions highly substituted with labeled amino acids.

It is a figure which shows the result of Examples 1-6. Changes in the substitution rate of stable isotope-labeled Pro constituting the labeled collagen produced from cells when the amount of stable isotope-labeled Pro added to the cell and the conditions of addition or non-addition of Gln are changed . It is a figure which shows the result of Examples 1-6. Changes in the substitution rate of stable isotope-labeled 4Hyp composing labeled collagen produced from cells when the amount of stable isotope-labeled Pro added to the cells and the conditions of addition or non-addition of Gln are changed . It is a figure which shows the result of the electrophoresis of the labeled collagen obtained in Example 1. Collagen type I and type III are mixed. It is a figure which shows the result of Example 12. Using the labeled collagen prepared in Example 8, the amount of collagen classified by type of rat skin, bone, and tail tendon was quantified. As a result, the skin-derived collagen had 22.3% collagen type III. Although included, about 99% of bone and tail tendon collagen was collagen type I. It is a figure which shows the result of Example 14. The post-translational modification of collagen extracted from rat skin, bone, and tail tendon was analyzed using the labeled collagen prepared in Example 13, and evaluated by the relative ratio between the tissues. Results such as a high 3Hyp composition amount were obtained. It is a figure which shows the result of Example 15. The line graph shows the transition of the amount of 4Hyp depending on the elapsed time of hydrolysis. On the other hand, the bar graph shows a change in the ratio of 4Hyp derived from the collagen to be measured and 4Hyp derived from the collagen to be labeled when the collagen to be measured and the labeled collagen prepared in Example 13 added are simultaneously hydrolyzed. It is a figure which shows the result of Example 16. The line graph shows the detected value of the 4Hyp standard as a percentage with respect to the absence of PBS, and the bar graph shows the value of the 4Hyp standard with respect to the labeled collagen-derived labeled 4Hyp as a percentage with no PBS added. Is. It is a figure which shows the result of Example 17, and shows the result of having measured unlabeled 4Hyp / labeled 4Hyp mass ratio, and measuring the density | concentration of blood free 4Hyp density | concentration, 4Hyp containing peptide, etc. In Example 17, it is a reference figure which shows the result of having measured the density | concentrations of blood free 4Hyp density | concentration, 4Hyp containing peptide, etc. based on the peak area of unlabeled 4Hyp. It is a figure which shows the result of Example 17, and shows the result of having measured the unlabeled oligopeptide / labeled oligopeptide mass ratio and measuring the oligopeptide concentration in blood. It is a figure which shows the result of Example 18, and when the intracellular uptake | capture amount was evaluated using the labeled collagen prepared in Example 13, degradation of the collagen in a cell was suppressed by E-64d administration. It is a figure which shows the result of the SDS modified | denatured polyacrylamide gel electrophoresis of the labeled collagen obtained in Example 20. FIG.

  In the first aspect of the present invention, at least one amino acid selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His constituting collagen is 90 mol of a corresponding labeled amino acid. %. A method for analyzing collagen using a labeled collagen obtained by post-translationally modifying a labeled collagen precursor substituted by at least%, and measuring a mixture of the labeled collagen and the target collagen or collagen-derived amino acid or peptide component And a method for analyzing collagen, comprising the peptide mass ratio measurement step and / or the amino acid mass ratio measurement step. Labeled collagen added to a measurement sample is used as an internal standard substance, and a labeled amino acid obtained by decomposing the labeled collagen with an acid or a peptide containing a labeled amino acid (hereinafter also referred to as a labeled peptide) is used as an internal standard substance. Can be used as When the labeled collagen is decomposed, a plurality of labeled amino acids and labeled peptides are generated, so that the labeled collagen functions as a bundle of these internal standard substances.

  The chemical properties of labeled collagen containing a labeled amino acid as a constituent amino acid are the same as those of unlabeled collagen that does not contain a labeled amino acid. Hydrolysis rate and enzymatic degradation rate, sample loss during the operation process, ionization in LC / MS analysis Efficiency etc. are also substantially the same. On the other hand, the mass varies depending on the content of stable isotope-labeled atoms. When mass analysis is performed on peptides and amino acids that are degradation products of these, labeled and unlabeled substances can be distinguished by mass difference. Therefore, if the mass ratio of the unlabeled body / labeled body is detected and the mass ratio is converted into the mass of the labeled collagen-derived component contained in the sample, the mass of the collagen-derived component to be measured contained in the measurement sample is quantified. Can do. Since the labeled collagen used in the present invention has a high substitution rate with the labeled amino acid, the collagen can be hydrolyzed with an acid or alkali, and for example, a highly accurate analysis such as quantification of the amount of post-translationally modified amino acid in the collagen can be performed. it can. Furthermore, it is possible to perform highly accurate analysis such as quantification of the type of collagen to be measured by LC / MS analysis of a specific peptide contained in the enzyme degradation product. Hereinafter, the present invention will be described in detail.

  As the “measurement target collagen” used in this analysis method, any conventionally known collagen such as pig, cow, bird, fish, human and the like can be targeted. Collagen forms a three-stranded helical structure in vivo, but the “measurement target collagen” is not limited to one that forms a three-stranded helical structure. In the present invention, the target collagen to be added to the measurement sample includes an amino acid composition or a peptide composition obtained by previously degrading the collagen with an acid, an alkali, an enzyme or the like. Accordingly, it may be gelatin or collagen peptide obtained by previously degrading collagen with acid, alkali, enzyme or the like.

  Further, “collagen-derived amino acid or peptide component” means an amino acid or peptide component to be measured originating from collagen. Collagen contains hydroxyproline (Hyp) in which proline is hydroxylated as a unique amino acid, for example, amino acids such as 3Hyp and 4Hyp, Hyp-containing peptides such as ProHyp, GluHyp and LeuHyp, and other collagen metabolites . Whereas the amino acid composition or peptide composition of the collagen to be measured is a composition containing all amino acids constituting the collagen molecule, “collagen-derived amino acid or peptide component” is a part of amino acids constituting the collagen molecule And some peptides may be different.

  The “labeled collagen” used in the present invention corresponds to at least one amino acid selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His constituting collagen. This is a post-translational modification of a labeled collagen precursor substituted with 90 mol% or more with a labeled amino acid. Here, “labeled collagen precursor” means a product produced by binding amino acids based on information of mRNA. The constituent amino acids of the collagen to be measured include post-translationally modified amino acids such as 4Hyp, 3Hyp, and Hyl, but they are not included in the labeled collagen precursor. For this reason, in this invention, it decided to use the labeled collagen by which the labeled collagen precursor was modified after translation.

The “labeled amino acid” constituting the labeled collagen precursor means an amino acid in which at least one atom constituting the amino acid is substituted with a stable isotope labeled atom. Therefore, it may be an amino acid substituted with deuterium (D) instead of hydrogen (H), an amino acid substituted with mass 13 carbon ( ¹³ C), and substituted with mass 15 nitrogen ( ¹⁵ N). Amino acids may be used. Note that the stable isotope-labeled atom needs to be present at a position contained in collagen when incorporated into collagen. As a labeled amino acid, Lys in which all of the carbon is substituted with ¹³ C (hereinafter, also referred to as ¹³ C ₆ -Lys), Arg in which all of the carbon is substituted with ¹³ C and all of the nitrogen is substituted with ¹⁵ N (hereinafter, ¹³ C ₆ ¹⁵ N ₄ -Arg), Pro in which all carbons are substituted with ¹³ C and all nitrogen atoms are substituted with ¹⁵ N (hereinafter also referred to as ¹³ C ₅ ¹⁵ N ₁ -Pro). It can be illustrated. However, it is not limited to these.

  The substitution rate with the labeled amino acid is 90 mol% or more, more preferably 95 mol% or more, and more preferably 97 mol% or more of each of the labeled amino acids used. If the substitution rate of the labeled collagen used is low, the peak of unlabeled collagen-derived peptide or amino acid contained as an impurity in the labeled collagen in LC / MS analysis is included in the peak of peptide or amino acid derived from the target collagen. Cannot quantify. In the present invention, measurement errors can be reduced and quantitativeness can be improved by using labeled collagen having a high substitution rate. The “substitution rate” in the present invention is measured by the method described in Examples described later.

  The labeled collagen used in the present invention may be prepared by any method. Therefore, the labeled amino acid may be used and chemically synthesized by the F-moc method, or the labeled collagen may be extracted from the tissue of an animal bred with food containing the labeled amino acid. However, chemical synthesis of collagen by the F-moc method is not easy, and collagen extracted from animal tissues has a high cost of food containing a labeled amino acid, and the post-translational modification amount may differ depending on age and disease. In the present invention, it is preferable to use collagen-producing cells. This is because post-translational modification of amino acids is constant and reproducibility is excellent. Here, the collagen-producing cells are cells that substantially produce collagen. For example, cells that originally have collagen-producing ability such as dermal fibroblasts may be used. For example, a collagen gene is introduced into cells that do not have collagen-producing ability such as CHO cells. It may be.

  When a labeled amino acid is added to a collagen-producing cell and cultured, a labeled collagen precursor is produced and immediately post-translationally modified. What is necessary is just to extract the collagen contained in a cell by destroying a cell, or after extracting the labeled collagen modified after translation from a culture supernatant or a deposit collagen layer, and refine | purifying as needed. Thereby, labeled collagen with a high substitution rate can be obtained.

  The collagen-producing cells to be used can be appropriately selected depending on the collagen type produced by the cells. For example, osteoblasts and tendon cells are used to obtain type I labeled collagen, and human fetal lung fibroblasts (HEL cells), skin fibroblasts, and stellate cells are used to obtain type I and type III labeled collagen. For example, rat chondrosarcoma cells (RCS cells) and chondrocytes can be exemplified to obtain type II, type IX, and type XI labeled collagen. In addition, any of the I-XXVIII type collagens can obtain labeled collagen by using the collagen-producing cells. A target collagen gene labeled collagen may be obtained by introducing a target collagen gene into a cell having no ability to produce collagen, such as CHO cells. Preferably, it is a collagen-producing cell in which the amino acid sequence before post-translational modification of the collagen to be produced has been elucidated.

  The amount of labeled amino acid added to the collagen-producing cells is preferably 20 to 300 mg, more preferably 40 to 250 mg, particularly preferably 40 to 200 mg per liter of the medium. Lys, Leu, Met, Phe, Thr, Val, Ile and His are essential amino acids, and Arg is a quasi-essential amino acid, so that a high substitution rate can be secured by supplying it as a labeled amino acid.

  However, when producing labeled collagen substituted with stable isotope-labeled Pro, 50 to 500 mg of stable isotope labeled Pro is added per liter of medium, more preferably 100 to 400 mg, and particularly preferably 150 to 350 mg. Pro is not an essential amino acid but other amino acids are converted in the cell to become Pro to form collagen, so that the substitution rate of stable isotope-labeled Pro tends to decrease. However, when the addition amount of the stable isotope labeled Pro is adjusted to the above range, the substitution rate with the stable isotope labeled Pro can be improved.

  Furthermore, as shown in the Examples described later, it was found that the substitution rate of stable isotope-labeled Pro can be further improved by culturing without supplying Gln to the medium. Even if Gln is not supplied, the amount of collagen synthesis is not suppressed, and labeled collagen can be produced in high yield.

  The culture time is 2 days or more, more preferably 3 days or more. Continuous culture may be used. Depending on the amount of labeled amino acid supplied, on the first day of culture, the unlabeled amino acid remaining in the cells is used to produce collagen, so the substitution rate is low. The replacement rate of becomes substantially flat. Labeled collagen precursors are produced by collagen-producing cells, and post-translational modifications are sequentially performed to form labeled collagen that is released outside the cell. In addition to labeled collagen, secretory proteins and serum-derived proteins may be mixed in the medium. When measuring by hydrolysis, if these impurities are mixed in labeled collagen, a measurement error occurs. When impurities are mixed, proteins other than collagen may be degraded with a proteolytic enzyme such as pepsin on the cultured medium, and labeled collagen may be purified by salting out. At this time, if a degradation reaction is performed using a proteolytic enzyme as an immobilized enzyme, contamination of these proteolytic enzymes can be avoided.

  The labeled collagen obtained by the above method is collected as a solution. The substitution rate of labeled collagen contained in the solution with a labeled amino acid is generally 90 mol% or more for each amino acid.

  In addition, since collagen type I is mainly produced when osteoblasts are used as collagen producing cells, collagen type I quantification by type, total collagen amount, post-translationally modified amino acid amount, etc. can be performed. . On the other hand, when dermal fibroblasts are cultured, collagen type III is mixed in addition to collagen type I. Using such a mixture of labeled collagen type I and type III, quantitative determination of total collagen, post-translationally modified amino acid amount, and type-specific determination of type I collagen and type III collagen contained in the sample it can. Similarly, depending on the purpose of analysis, whether it contains only a specific type of collagen or two or more different types of collagen, type-based quantification, total collagen quantification, post-translational modification quantification Can be done.

  As the labeled collagen, labeled collagen containing stable isotope-labeled Pro and / or stable isotope-labeled Lys, and further substituted with at least one labeled amino acid of Arg, Leu, Met, Phe, Thr, Val, Ile and His There is labeled collagen. It can select suitably according to the measurement item of a collagen to be measured. In particular, when an amino acid that does not undergo post-translational modification such as Arg (hereinafter also referred to as an unmodified amino acid) is included, the mass ratio between the unmodified amino acid derived from the labeled collagen and the unmodified amino acid derived from the collagen to be measured is determined. It can be used to quantify the amount of amino acids per collagen. As such labeled amino acids, stable isotope-labeled Arg, stable isotope-labeled Val, and stable isotope-labeled Leu are preferable, and more preferably, because the content in collagen is high and the composition ratio in collagen is stable. It is a stable isotope labeled Arg. When collagen is digested with, for example, trypsin, the C-terminus becomes stable isotope-labeled Arg or stable isotope-labeled Lys, so that at least one or more labeled amino acids can be contained per peptide.

  In addition, in this invention, the labeled collagen added to a measurement sample shall include the case where it is an amino acid composition and a peptide composition which decompose | disassemble this beforehand with an acid, an alkaline enzyme, etc. In addition, stable isotope-labeled Pro and degradation products of labeled collagen substituted with stable isotope-labeled Lys include post-translationally modified amino acids in addition to stable isotope-labeled Pro and stable isotope-labeled Lys derived from labeled collagen, Stable isotope labeled 4Hyp, stable isotope labeled 3Hyp, stable isotope labeled Hyl, stable isotope labeled GHL, stable isotope labeled GGHL, and peptides containing these are included.

  The amino acid composition of the labeled collagen can be determined by, for example, preparing an amino acid composition by decomposing the labeled collagen with an acid or alkali and analyzing the mass ratio of each amino acid by LC / MS. Further, the total collagen concentration of the labeled collagen can be calculated from the total amino acid amount. Furthermore, a known amount of purified collagen type I and labeled collagen are both enzymatically decomposed, and the mass ratio of the predetermined peptide derived from purified collagen type I to the predetermined peptide derived from labeled collagen is determined by LC / MS. The concentration of labeled collagen type I can be determined by multiplying the mass of purified collagen type I. The concentration of collagen type II can be quantified according to the above.

  Hereinafter, a method for analyzing collagen using the labeled collagen will be described in detail.

  The measurement sample used in the analysis method of the present invention includes labeled collagen and a collagen to be measured or a collagen-derived amino acid or peptide component. As described above, the collagen to be measured and the labeled collagen may be undegraded collagen, or may be an amino acid composition or a peptide composition that has been previously degraded. If the decomposition treatment is performed on the mixture of the collagen to be measured and the labeled collagen, the error between the two produced in the decomposition process can be offset. When analyzing collagen-derived amino acids or peptide components in place of the collagen to be measured, analysis can be performed after appropriate hydrolysis and enzymatic decomposition according to the purpose of analysis and further decomposition.

  As acids and alkalis that hydrolyze collagen into amino acids, various acids and alkalis conventionally used for protein degradation can be used, and amino acids may be obtained by enzymatic degradation. Moreover, endopeptidase is suitable as an enzyme for obtaining a peptide from collagen. For example, trypsin, Lys-C endopeptidase, lysyl endopeptidase, Arg-C endopeptidase, chymotrypsin and the like can be exemplified, and peptides may be obtained by acid or alkaline degradation. When an enzyme is used, trypsin in which the C-terminus is Arg or Lys is preferable. When the labeled collagen substituted with stable isotope-labeled Arg or stable isotope-labeled Lys is decomposed with trypsin, the C-terminus becomes stable isotope-labeled Arg or stable isotope-labeled Lys, and a peptide with an amino acid length suitable for LC / MS analysis Can be obtained.

  In the present invention, analysis and quantification of the collagen type can be performed by using a peptide specific to the collagen type as a measurement target. As a type-specific peptide serving as an index in such LC / MS analysis, the number of amino acids is 8 to 20, it contains 1 or more, more preferably 2 or more labeled amino acids, and has an amino acid sequence specific to collagen type. There are peptides. In the present invention, as such an indicator peptide, for example, GVQGPOGPAGPR (O represents 4Hyp), GVVGLOGQR, EGPVGLOGIDGR, GPSGPQGIR, GIVOGLOGQR, GSOGAQGLQGPR, GROLOGOGARPG, GLOPGOGOGPR, GPOGOGOGPR, GPOOGIOPG It can be preferably used. GVQGPOGPAGPR, GVVGLOGQR, EGPVGLOGIDGR and GPSGPQGIR are sequences specific to collagen type I. Therefore, qualitative and quantitative determination of collagen type I can be performed. This amino acid sequence is common to collagen type I such as human, bovine, rat and mouse. Therefore, the above peptides can be used to perform type-specific quantification of collagen derived from these animal species. Similarly, GIVGLOGQR and GSOGAQGLQGPR are sequences specific to collagen type II, GROLOGAGAAR and GLAGPOGMMOGPR are sequences specific to collagen type III, GPOGIOGAOGK and GPTGELGDDOGPPR are sequences specific to collagen type IX, and LGVOGLOGY collagen This is a sequence peculiar to V type and XI type. Any of them can be suitably used for quantification of collagen by type. Such type-specific peptides can be generated by degrading collagen with trypsin.

  In the present invention, the measurement sample amino acid mass ratio and the measurement sample peptide mass ratio are quantified by LC / MS analysis. The LC / MS analysis can be performed by a conventionally known method using a conventionally known apparatus. The measurement sample amino acid mass ratio and the measurement sample peptide mass ratio can be quantified by measuring the peak height and peak area of a predetermined component in mass spectrometry.

(1) Method for quantifying the amount of amino acids constituting collagen The amino acids constituting collagen are usually expressed by converting the number of amino acid residues in 1 mole of collagen into the number of amino acid residues per 1000 collagen residues. According to the present invention, the labeled collagen can be used to quantify the composition ratio of amino acids constituting the collagen to be measured.

  As the labeled collagen to be used, Pro or Lys to be measured is substituted by 90 mol% or more with a labeled amino acid, and at least selected from the group consisting of Arg, Leu, Met, Phe, Thr, Val, Ile and His. A post-translationally modified labeled collagen precursor substituted with 90 mol% or more with one or more labeled amino acids is used. For convenience, labeled post-translationally modified Pro and post-translationally modified Lys are used using post-translationally modified labeled collagen precursor substituted with stable isotope labeled Pro, stable isotope labeled Lys, and stable isotope labeled Arg. The case of quantifying will be described.

  First, a known amount of labeled collagen is added to the collagen to be measured to obtain a measurement sample. The collagen to be measured and the labeled collagen may be obtained by combining those previously decomposed into amino acids into a measurement sample, or an amino acid composition obtained by simultaneously decomposing a mixture of both may be used as the measurement sample. In addition, when collagen is hydrolyzed with an acid, sugar chains contained in GHL and GGHL may be cleaved, and it is preferable to appropriately select and combine acid hydrolysis, alkaline hydrolysis, and enzymatic degradation according to the purpose. For example, by analyzing an acid hydrolyzate, 4Hyp or 3Hyp or Lys whose Pro is modified after translation is quantified, and GHL or GGHL or the like is quantified using an alkaline hydrolyzate. be able to.

  The type of labeled collagen used is preferably the same as the collagen to be measured. This is because the content of 3Hyp, GGHL, and the like may differ depending on the type of collagen. Since 4Hyp and Arg have almost the same content in many major collagen types such as type I, type II, type III, etc., labeled collagen type I is used when quantifying 4Hyp of any collagen type can do.

  When quantifying the 4Hyp constituting the measurement target collagen, the labeled collagen-derived stable isotope labeled 4Hyp (hereinafter sometimes referred to as labeled 4Hyp) and the measurement target collagen-derived 4Hyp (hereinafter referred to as LCH) are analyzed by LC / MS analysis. , Sometimes referred to as unlabeled 4Hyp.), For example, unlabeled 4Hyp / labeled 4Hyp. Similarly, the mass ratio of stable isotope labeled Arg (hereinafter sometimes referred to as labeled Arg) and unlabeled Arg (hereinafter sometimes referred to as unlabeled Arg), for example, unlabeled Arg / labeled Arg Measure.

When the mass of the labeled collagen-derived 4Hyp added to the measurement sample is _Y4Hyp , if _Y4Hyp × unlabeled 4Hyp / labeled 4Hyp = Z _4Hyp is calculated, the mass of the 4Hyp derived from the measurement target collagen contained in the measurement sample is calculated as Z _4Hyp. Can be obtained as

In order to obtain the amount of 4Hyp per mole of the collagen to be measured contained in the measurement sample, the following conversion may be performed. Since Arg constituting collagen has a stable composition ratio in collagen, the unlabeled Arg / labeled Arg of the measurement sample corresponds to the molar ratio of the target collagen to the labeled collagen contained in the measurement sample. If the amount of labeled collagen added to the measurement sample is _MSI mol, _MSI × unlabeled Arg / labeled Arg corresponds to the number of moles M _Sam of the target collagen contained in the measurement sample. _{Z 4Hyp / M Sam = Y 4Hyp} × ( unlabeled 4Hyp / label 4Hyp) × (labeled Arg / _{(M SI} × unlabeled Arg)) by calculating a be determined 4Hyp amount per 1 mole of measured collagen it can.

In the same manner as determination of the 4Hyp, Pro, Lys, Hyl, GHL, amino acids such as GGHL also mass was added to the sample labeled collagen constituent amino acids and _{Y A,} the labeled amount of collagen added to sample _{M SI} In the case of mol, Y _A × (unlabeled amino acid / labeled amino acid) × (labeled Arg / ( _MSI × unlabeled Arg)) can be calculated, and the amino acid per mole of collagen to be measured can be quantified. In addition to the above-mentioned Arg, amino acids having a stable composition ratio in collagen such as Leu, Met, Phe, Thr, Val, Ile, and His are used to indicate the blending ratio of collagen to be measured and labeled collagen. can do. When Leu is used as an index instead of Arg, a labeled collagen substituted by 90 mol% or more with stable isotope-labeled Leu is used instead of stable isotope-labeled Arg. In the present invention, stable isotope-labeled amino acids obtained by decomposing labeled collagen can be treated as internal standard substances, and therefore a plurality of amino acids can be quantified simultaneously.

In order to calculate the number of amino acid residues per 1000 collagen residues, the number of amino acid residues per 1000 amino acid residues constituting the labeled collagen measured in advance may be used. For example, (unlabeled amino acid / labeled amino acid) / (unlabeled Arg / labeled Arg) is a mass ratio of the measurement target amino acid to the labeled collagen constituting amino acid per collagen. Thereto, multiplied by M _A as residues per 1000 residues of the amino acids constituting the labeled collagen, by calculating the M _A × (non-labeled amino acids / labeled amino acids) × (labeled Arg / unlabeled Arg), The number of residues per 1000 residues of the amino acid of the collagen to be measured can be calculated.

(2) Method for quantifying collagen amount The labeled collagen used is 90 mol% of at least one or more labeled amino acids selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile, and His. The above is a post-translational modification of the substituted labeled collagen precursor. Preferably, a labeled collagen precursor in which Pro is substituted with stable isotope-labeled Pro by 90 mol% or more is post-translationally modified. 4Hyp whose Pro is post-translationally modified is a post-translationally modified amino acid present only in collagen. When LC / MS analysis is performed using the 4Hyp amount as an index, the amount of collagen to be measured can be accurately quantified even if the collagen to be measured contains a protein other than collagen. For convenience, explanation will be given for the case of using labeled collagen substituted with stable isotope-labeled Pro.

  A known amount of labeled collagen is added to the collagen to be measured to obtain a measurement sample. The collagen to be measured and the labeled collagen may be those obtained by previously separately decomposing them into amino acids to form a measurement sample, or those obtained by mixing the two and then simultaneously decomposing them may be used as the measurement sample. In the case where the collagen to be measured and the labeled collagen are simultaneously decomposed, the measurement error due to the decomposition process can be offset.

The obtained degradation product is measured by LC / MS analysis, for example, the mass ratio of 4Hyp derived from collagen to be measured to stable isotope labeled 4Hyp derived from labeled collagen, for example, unlabeled 4Hyp / labeled 4Hyp. When, for example, Y _C is multiplied as the mass of the labeled collagen added to the measurement sample, Y _C × (unlabeled 4Hyp / labeled 4Hyp) is the mass of the collagen to be measured in the measurement sample.

  Although the above quantification method uses 4Hyp as an index, 4Hyp is an amino acid that is specifically contained in collagen, there is little variation between collagen tissues, and there are no reports of major changes other than scurvy. This is because the constituent amount in collagen is also stable. Therefore, when the target collagen does not contain impurities such as other proteins, it is selected from the group consisting of Pro, Arg, Leu, Met, Phe, Thr, Val, Ile and His instead of 4Hyp. The mass ratio of any amino acid can be quantified, and the total collagen amount can be quantified. In this case, 90 mol% or more of at least one or more labeled amino acids selected from the group consisting of Pro, Arg, Leu, Met, Phe, Thr, Val, Ile, and His corresponding to the amino acid to be measured. A labeled collagen obtained by post-translationally modifying the substituted labeled collagen precursor is used. In general, amino acid compositions other than 4Hyp differ between collagen types. Therefore, when an amino acid other than 4Hyp is used as an index, the type of labeled collagen used is the same as the collagen to be measured.

  The above-described quantification of the total amount of collagen can be measured even with a small amount of sample because the sensitivity when measuring the mass ratio of amino acids such as 4Hyp is high. When the amount of collagen is quantified by measuring a peptide having a specific sequence of collagen, the content of such specific sequence peptide is basically 1 mol per 1 mol of protein, but 4Hyp and other amino acids per 1 mol of collagen. Since the number of moles is large, the measurement sensitivity can be improved by 100 times or more compared to the case of using a peptide as a measurement target. Since the labeled collagen used in the present invention has a high substitution rate with the labeled amino acid and high purity, such highly sensitive amino acid can be measured.

(3) Quantification method of type-specific collagen The labeled collagen used for analysis of type-specific collagen is at least selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile and His. It is labeled collagen in which 90 mol% or more is substituted with one or more labeled amino acids. When analyzing the concentration of collagen type I contained in the collagen to be measured, collagen type I labeled collagen is used. For convenience, stable isotope-labeled Pro, stable isotope-labeled Lys, and labeled collagen type I modified with post-translationally labeled collagen type I precursor substituted with stable isotope-labeled Arg are used and included in the measurement sample. The case where the collagen type I to be measured is quantified will be described.

  First, a known amount of labeled collagen type I is added to the collagen to be measured to obtain a measurement sample. The collagen to be measured and the labeled collagen may be those obtained by combining enzymatic digests separately using the same endopeptidase in advance to make a measurement sample, and those that have been enzymatically digested simultaneously using endopeptidases. It is good also as a measurement sample.

  Next, by LC / MS analysis, a peptide derived from labeled collagen (hereinafter referred to as labeled type I peptide) contained in the measurement sample, using a peptide containing an amino acid sequence unique to collagen type I and containing a labeled amino acid as an index. The mass ratio of the peptide derived from the collagen to be measured corresponding to the labeled type I peptide (hereinafter referred to as unlabeled type I peptide) is measured. Stable isotope-labeled Pro, stable isotope-labeled Lys, and labeled collagen type I substituted with stable isotope-labeled Arg are enzymatically decomposed with trypsin, and Pro, 4Hyp, 3Hyp, Lys, Hyl, Arg, etc. are composed of labeled amino acids The obtained peptide is obtained. Therefore, as a peptide having an amino acid sequence peculiar to collagen type I, for example, by performing LC / MS analysis using GVQGPOGPAGPPR, GVVGLOGQR, EGPPVLOGIDGR, GPSGPQGIR, etc. as an index, it is possible to absorb errors in ionization efficiency at the time of measurement. Quantitative analysis can be performed.

  When the mass ratio is measured using GVQGPOGGPAGPR as an index, for example, the mass ratio between the labeled collagen-derived peptide (hereinafter referred to as labeled GVQGPOGGPAGPR) and the target collagen derived peptide (hereinafter referred to as unlabeled GVQGPOGGPAGPR) is, for example, The unlabeled GVQGPOGPAGPPR / labeled GVQGPOGGPAGPR is calculated, and the mass of the collagen I to be measured contained in the measurement sample is multiplied by YCI as the mass of the labeled collagen type I added to the measurement sample. It can be calculated from GVQGPOGAPAGPR.

  The above is exemplified when a known amount of labeled collagen type I is used. However, as the labeled collagen, type II, type III, and others may be mixed. This is because if the amount of type I added is known, measurement errors will not occur even if other collagens are included.

On the other hand, when type I collagen and type III collagen are contained in the collagen to be measured, if a labeled collagen in which a known amount of labeled collagen type I and a known amount of labeled collagen type III are mixed is used, a single measurement can be performed. Type I and type III can be quantified.
LC / MS analysis of the enzymatic digestion solution of the measurement sample was conducted, and a peptide having an amino acid sequence specific to collagen type I (hereinafter referred to as a type I index peptide) and a peptide having an amino acid sequence specific to collagen type III (hereinafter referred to as “type I index peptide”). (Referred to as type III indicator peptide) by LC / MS analysis. When the type I index peptide and the type III index peptide are detected, the collagen to be measured includes collagen type I and type III. In the same manner as described above, the mass of the peptide derived from the collagen type I to be measured (hereinafter referred to as unlabeled type I peptide) and the peptide derived from the labeled collagen type I (hereinafter referred to as labeled type I peptide). The ratio, for example, unlabeled type I peptide / labeled type I peptide is measured, and YCI is multiplied by the mass of labeled collagen type I added to the measurement sample to calculate YCI × unlabeled type I peptide / labeled type I peptide. For example, the mass of collagen type I contained in the measurement sample can be determined. The same applies to collagen type III. If the mass of labeled collagen type III added to the measurement sample is multiplied by YCIII and YCIII × unlabeled type III peptide / labeled type III peptide is calculated, collagen type III contained in the collagen to be measured Can be obtained.

  In the collagen type quantification method, a labeled collagen containing a plurality of types of collagen types in known amounts in advance may be used. For example, qualitative analysis of collagen type by preparing labeled collagen containing a predetermined amount of collagen type I, type II, type III and type IV in advance, and detecting peptides specific to each collagen type contained in the collagen to be measured And quantitative analysis can be performed.

(4) Determination of the amount of peptide The method for measuring the amount of peptide constituting collagen can be performed according to the above-described method for determining the amount of collagen by type. The case where the amount of GlyProAla in the collagen to be measured is quantified by degrading with collagenase using labeled human collagen type I will be described.
A known amount of labeled collagen type I is added to the collagen to be measured to obtain a measurement sample. The collagen to be measured and labeled collagen type I may be those obtained by combining the enzymes previously decomposed separately using the same collagenase into a measurement sample, or those that have been enzymatically decomposed simultaneously using collagenase. It is good also as a measurement sample.
Subsequently, by LC / MS analysis, the mass of labeled GlyProAla (hereinafter referred to as labeled GPA) contained in the measurement sample and GlyProAla (hereinafter referred to as unlabeled GPA) derived from the collagen to be measured corresponding to the labeled GPA. The ratio (unlabeled GPA / labeled GPA) is measured.
Collagenase degrades collagen in Gly-XY units, and when the degradation reaction is completely carried out, 1 mol of labeled collagen type I to 88 mol of GlyProAla (from α1 chain to 30 × 2 = 60 mol, from α2 chain) 28 mol) is produced. The molecular weight of GlyProAla 243, since the molecular weight of collagen is about 3 × 10 ^5, if the weight was added to the sample labeled collagen and _{Y CI,} mass _{Y GPA} labels GPA contained in the measurement sample _{Y CI} × The mass of GPA calculated by 88 × 243 / (3 × 10 ⁵ ) and constituting the collagen to be measured can be obtained as Y _GPA × (unlabeled GPA / labeled GPA).
In the present invention, since a number of peptides represented by Gly-XY produced by degrading labeled collagen with collagenase can be handled as internal standard substances, a plurality of peptides can be quantified simultaneously as described above. .

(5) Quantification of collagen-derived amino acid or peptide component According to the analysis method of the present invention, for example, a sample obtained by adding a known amount of labeled collagen to plasma is used as a measurement sample, whereby collagen-derived amino acid or peptide component in plasma is used. Can be quantified.
The mass ratio between the collagen-derived peptide component contained in the measurement sample and the corresponding labeled collagen-derived peptide corresponding thereto and the mass ratio between the collagen-derived amino acid and the corresponding labeled collagen-derived amino acid are measured in advance. Collagen-derived amino acids and peptide components contained in the measurement sample can be quantified using a calibration curve of the mass ratio of the peptide and the mass ratio of the amino acid prepared using the preparation and labeled collagen. Examples of quantitative objects containing collagen-derived amino acids and peptide components include biological components containing collagen metabolites such as whole blood, plasma, serum, urine, and tissue extracts. It is suitable for measurement of collagen metabolites contained in these quantitative objects.

(I) Quantification of Collagen-Derived Amino Acids A case where plasma is used as a quantification target and 4Hyp is measured as a collagen metabolite will be described.
The labeled collagen used is a labeled collagen obtained by post-translationally modifying a labeled collagen precursor in which at least 90% by mole of Pro constituting the collagen is substituted with a labeled amino acid. A known amount of labeled collagen degradation product that has been previously decomposed to contain an amino acid with an acid, alkali, or enzyme is added to plasma to obtain a measurement sample. The supernatant obtained by precipitating this measurement sample with ethanol contains free 4Hyp. The supernatant is analyzed by LC / MS, and the mass ratio (unlabeled 4Hyp / labeled 4Hyp) of plasma-derived 4Hyp (unlabeled 4Hyp) to labeled collagen-derived 4Hyp (labeled 4Hyp) contained in the supernatant is measured. Separately, commercially available 4Hyp and the labeled collagen degradation product are mixed at a predetermined mass ratio to prepare a standard solution row, and the unlabeled 4Hyp / labeled 4Hyp mass ratio is measured by LC / MS. A calibration curve showing the above relationship is prepared, and the amount of free 4Hyp in plasma is quantified from the mass ratio measured above based on this calibration curve.

  The supernatant contains peptide type 4Hyp together with free type 4Hyp. Therefore, if this supernatant is decomposed with an acid or the like to decompose peptides contained in plasma into amino acids, and this decomposed product is used and quantified in the same manner as described above, the total 4Hyp contained in plasma can be quantified. Can do. The difference between the total amount of 4Hyp and the amount of free 4Hyp is the amount of peptide type 4Hyp contained in plasma.

  In the present invention, each labeled amino acid obtained by decomposing labeled collagen can be handled as an internal standard substance. Therefore, by using a labeled collagen containing the corresponding labeled amino acid, a substance other than the above 4Hyp contained in the measurement sample can be used. Multiple amino acids can be quantified simultaneously.

(Ii) Quantification of Collagen-Derived Peptide Component A case where plasma is used as a quantification target and ProHyp is measured as a collagen metabolite will be described.
The labeled collagen used is a labeled collagen obtained by post-translationally modifying a labeled collagen precursor in which at least 90% by mole of Pro constituting the collagen is substituted with a labeled amino acid. A known amount of labeled collagen degradation product that has been previously decomposed to contain a peptide with acid, alkali, or enzyme is added to plasma to obtain a measurement sample. The supernatant obtained by precipitating this measurement sample with ethanol was analyzed by LC / MS, and the mass ratio of non-labeled ProHyp (unlabeled ProHyp) to non-labeled ProHyp (labeled ProHyp) contained in the measurement sample (non-labeled ProHyp) Labeled ProHyp / labeled ProHyp) is measured. Separately, the synthetic oligopeptide ProHyp and the labeled collagen degradation product are mixed at a predetermined mass ratio to prepare a standard solution row, and the unlabeled ProHyp / labeled ProHyp mass ratio is measured by LC / MS. This value and the ProHyp concentration A calibration curve showing the relationship between and the amount of peptide in plasma is quantified from the mass ratio measured above based on this calibration curve.

In the present invention, each labeled peptide obtained by degrading labeled collagen can be treated as an internal standard substance at the time of measurement. Therefore, by using the labeled collagen, a plurality of peptides other than the above-mentioned ProHyp are simultaneously quantified. be able to. Furthermore, the labeled collagen degradation product may contain an amino acid and a peptide at the same time. By using such a labeled collagen degradation product as an internal standard substance, amino acids and peptides can be measured simultaneously.
(6) Relative ratio evaluation In the present invention, the quantitative methods include "absolute quantification" and "relative quantification". Therefore, when analyzing the collagen of a plurality of measurement samples, the amino acid amount, the peptide amount, the collagen amount, and the type-specific collagen amount obtained by the analysis method of the present invention based on the value of any one of the measurement samples as a relative ratio. Can be evaluated. For example, if the amount of labeled collagen and the amount of collagen to be measured contained in each measurement sample are constant among multiple measurement samples, the measurement sample is obtained using only the measurement sample peptide mass ratio or the measurement sample amino acid mass ratio obtained by analysis. There is an advantage that a difference between them can be easily detected. Even when the amount of labeled collagen added to the measurement sample and the amount of collagen to be measured are different among the plurality of measurement samples, the difference between the measurement samples can be accurately evaluated by the relative ratio.

  (I) A plurality of measurement samples in which the labeled collagen and the collagen to be measured contained in the measurement sample are constant can be evaluated by the following method. As such a sample, there is a hydroxylated sample of denatured collagen by proline hydroxylase. The case where the hydroxylation state of the collagen sample is observed n times every predetermined time, and the hydroxylation state of Pro is described as a case where the relative ratio is obtained on the basis of 0:00 reaction.

  As the labeled collagen to be used, at least one selected from the group consisting of Arg, Leu, Met, Phe, Thr, Val, Ile and His is substituted with 90% by mole or more of Pro as a measurement target with a labeled amino acid. There is a post-translational modification of a labeled collagen precursor in which 90 mol% or more is substituted with the above labeled amino acid. For convenience, when using labeled collagen obtained by post-translationally modifying a labeled collagen precursor substituted with stable isotope-labeled Pro and stable isotope-labeled Arg, the difference between 4Hyp measurement samples generated by hydrolysis is evaluated. I will explain it.

A part of the collagen to be measured is taken out from the collagen to be measured n times every predetermined time, and an equal amount of labeled collagen is added to the collagen to be measured to make a measurement sample. This is hydrolyzed with acid or alkali, for example. The mass ratio of stable isotope labeled 4Hyp to unlabeled 4Hyp, for example, unlabeled 4Hyp / labeled 4Hyp, is measured by LC / MS analysis. As described in (1) above, when the amount of 4Hyp derived from labeled collagen added to the measurement sample is known, for example, _Y4Hyp , _Y4Hyp × unlabeled 4Hyp / labeled 4Hyp is calculated, and the measurement sample It is possible to calculate the amount of 4Hyp derived from the collagen to be measured contained in. Further, if the label amount of collagen was added to the measurement sample and _{M SI mole,} by calculating the _{Y 4Hyp} × (unlabeled 4Hyp / label 4Hyp) × (labeled Arg / _{(M SI} × unlabeled Arg)), measuring The amount of 4Hyp per mole of target collagen can also be calculated.

On the other hand, the mass ratio of at reaction 0 represents an initial value _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) 0} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 0}} at _0, the mass during each measurement the ratio of the _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) 1} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 1} 1, ···} , {Y 4Hyp × ( unlabeled 4Hyp / label _{4Hyp) n} × if (labeled Arg / _{(M SI} × unlabeled _{Arg)) n} n, {} Y 4Hyp × ( unlabeled 4Hyp / label _{4Hyp) n} × (labeled Arg / _{(M SI} × unlabeled _Arg)) n} _n / _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) 0} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 0}} 0 by calculating a relative ratio with respect to the initial value 4Hyp amount at each elapsed Can be evaluated. In the above formula, “Y 4 _Hyp ” and “labeled Arg / (M _SI × unlabeled Arg)” are the same between the measurement samples. Therefore, by using “unlabeled 4Hyp / labeled 4Hyp” as the mass ratio at the time of each measurement and calculating (unlabeled 4Hyp / labeled 4Hyp) _n / (unlabeled 4Hyp / labeled 4Hyp) ₀ , the elapsed time from the initial value The relative ratio of n can be obtained. This method is excellent in that it can be analyzed without calculating the amount of 4Hyp derived from the collagen to be measured using labeled collagen of unknown concentration.

  The above is explained in the case of analyzing the time course of 4Hyp. Instead of hydrolysis with acid or alkali added to the measurement sample, the amount of peptide generated by enzymatic degradation is analyzed over time by LC / MS analysis. Changes over time can also be analyzed.

  (Ii) Although the amount of labeled collagen contained in the measurement sample is constant, a plurality of measurement samples having different measurement target collagen amounts can be evaluated by the following method. The amount of collagen 4Hyp extracted from tissues affected by different diseases will be described in the case of obtaining a relative ratio with reference to the healthy time.

  The labeled collagen to be used is at least 90 mol% of Pro or Lys to be measured is substituted with a labeled amino acid, and at least selected from the group consisting of Arg, Leu, Met, Phe, Thr, Val, Ile and His. This is a post-translationally modified labeled collagen precursor in which 90 mol% or more is substituted with one or more labeled amino acids. For convenience, description will be made on the case where 4Hyp contained in each measurement sample is evaluated using labeled collagen obtained by post-translationally modifying a labeled collagen precursor substituted with stable isotope labeled Pro and stable isotope labeled Arg.

  The same amount of labeled collagen is added to each collagen to be measured extracted from tissues affected by different diseases during health and used as a measurement sample. The collagen to be measured and the labeled collagen may be obtained by combining those hydrolyzed separately in advance to obtain a measurement sample, or may be obtained by mixing both and simultaneously hydrolyzing.

Subsequently, the mass ratio of stable isotope labeled 4Hyp and unlabeled 4Hyp contained in the hydrolyzate, for example, unlabeled 4Hyp / labeled 4Hyp, is measured by LC / MS analysis. As described in the above (1), if the 4Hyp amount contained in the labeled collagen was added to the sample and _{Y 4Hyp,} calculates the _{Y 4Hyp} × unlabeled 4Hyp / label 4Hyp, measured collagen contained in the measurement sample The amount of 4Hyp derived can be calculated. The "unlabeled 4Hyp / label 4Hyp" arithmetic value of two mass ratio of "labeled Arg / unlabeled Arg", addition of labeled amount of collagen was added in the measurement sample as a _{M SI mol, Y 4Hyp} × ( unlabeled 4Hyp / label 4Hyp) by calculating a × (labeled Arg / _{(M SI} × unlabeled Arg)), can be obtained 4Hyp amount per 1 mole of measured collagen.

On the other hand, represents the weight ratio in healthy as an initial value _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) 0} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 0}} at _0, the mass ratio of each disease _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) 1} × (labeled Arg _{/ (M SI1} × unlabeled _{Arg)) 1} 1, ···} , {Y 4Hyp × ( unlabeled 4Hyp / label _{4Hyp) n} × ( Labeled Arg / ( _MSI × unlabeled Arg)) _n } _n . Weight ratio in each disease to healthy at the time _{of, {Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) n} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) n} n / {} Y 4Hyp × ( unlabeled 4Hyp / label _{4Hyp) 0} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 0}} 0 become. Since 4Hyp amount and labeled collagen amount _{M SI} contained in the labeled collagen was added to the measurement sample is constant, {(unlabeled 4Hyp / label _{4Hyp) n} × (labeled Arg / unlabeled _{Arg) n} n} / {(non By calculating labeled 4Hyp / labeled 4Hyp) ₀ × (labeled Arg / unlabeled Arg) ₀ } ₀ , the relative ratio of each measurement sample to normal can be evaluated.

  From the above formula, even when the amount of collagen to be measured contained in the measurement sample is different, the relative ratio between the measurement samples can be easily obtained using only the mass ratio obtained in the mass ratio measurement step. The above is an example in which “unlabeled 4Hyp / labeled 4Hyp”, which is the mass ratio of each measurement sample, and “labeled Arg / unlabeled Arg” are evaluated in combination.

  In LC / MS analysis, it is possible to determine the amount of 4Hyp from the peak area of 4Hyp derived from the collagen to be measured using a calibration curve prepared with a 4Hyp sample. However, as shown in the examples described later, When the sample contains a contaminating component such as salt, a quantitative error due to a measurement error between samples tends to occur. Even in such a case, a labeled 4Hyp obtained by degrading the labeled collagen is added to the measurement sample and the calibration curve sample and used as an internal standard substance, and measurement error is caused by measuring unlabeled 4Hyp / labeled 4Hyp. Can be offset and accurate quantification can be performed.

(Iii) The relative ratios of a plurality of measurement samples having different amounts of labeled collagen and measurement target collagen contained in the measurement sample can be evaluated by the following method. The case where the amount of labeled collagen is different in the measurement sample (ii) will be described.
If the labeled amount of collagen was added to the measurement sample and _{M SI} molar mass ratio of the time the disease to healthy at the time of _{{Y 4Hyp} × (unlabeled 4Hyp / label _{4Hyp) n} × (labeled Arg / _{(M SI} × unlabeled Arg _{)) n} n / {Y} 4Hyp × ( unlabeled 4Hyp / label _{4Hyp) 0} × (labeled Arg / _{(M SI} × unlabeled _{Arg)) 0}} is _0. Since the amount of labeled collagen contained in the measurement sample is different, the added labeled collagen content M _SI mol 4Hyp amount of measurement sample was added to each sample, different for each sample. However, since the ratio of the 4Hyp amount constituting the labeled collagen and the added labeled collagen content in the measurement sample is constant, Y _{4Hyp /} M _SI is the same in any of the measurement sample. Therefore, when evaluating by relative ratio, {(unlabeled 4Hyp / labeled 4Hyp) _n × (labeled Arg / unlabeled Arg) _n } _n / {(unlabeled 4Hyp / labeled 4Hyp) as in (ii) above ₀ × (labeled Arg / unlabeled Arg) ₀ } ₀ can be calculated, and the difference of each measurement sample with respect to normal can be detected.

As described above, the evaluation of the relative ratio in the collagen analysis method of the present invention has been described by classifying the amount of labeled collagen and the amount of collagen to be measured contained in the measurement sample as constant or indefinite, but the present invention is not limited to this. For example, in the above embodiment (i), the amount of labeled collagen and the amount of collagen to be measured are equal among a plurality of measurement samples, as in (iii) above, {(unlabeled 4Hyp / labeled 4Hyp) _n × (labeled Arg / Unlabeled Arg) _n } _n / {(unlabeled 4Hyp / labeled 4Hyp) ₀ * (labeled Arg / unlabeled Arg) ₀ } ₀ may be calculated.

(7) Analysis of intracellular uptake amount By applying the analysis method of the present invention, the uptake amount of labeled collagen by cells can be quantified. Conventionally, radioisotope iodine-labeled collagen and fluorescently-labeled collagen have been used for measuring the amount of collagen taken into cells. However, in these methods, the whole collagen is not uniformly labeled, and since the molecular weight of the labeled substance is large, there is a possibility that physical properties may change, and there is a concern that accurate quantification may be hindered. In the labeled collagen used in the present invention, the labeled amino acid is uniformly incorporated into the entire collagen sequence, and the physical properties of the labeled collagen are not changed, so that the accurate amount of collagen incorporated into the cell can be measured.

Specifically, labeled collagen is added to the culture system, and the incorporated labeled collagen is acid-hydrolyzed together with the cells, and then the labeled amino acid derived from the labeled collagen, such as 4Hyp, is quantified. According to the above method, since the labeled amino acid derived from the labeled collagen is quantified, the influence of the amount of unlabeled amino acid other than endogenous collagen synthesized in the cell can be eliminated.
In the labeled collagen, since the labeled amino acid is uniformly incorporated into the collagen, the intracellular uptake amount of the collagen peptide decomposed with an enzyme or the like can be measured in the same manner as the incorporation of the labeled collagen.

  EXAMPLES Next, although an Example is given and this invention is demonstrated concretely, these Examples do not restrict | limit this invention at all.

Example 1
The HEL cells _{^{1.5 × 10 6 cells, 13 C}} 6 -Lys (Thermo scientific , ^{_{Inc.) 100mg / L, 13 C 6}} 15 N 4 -Arg (Thermo scientific , ^{_{Inc.) 100mg / L, 13 C 5}} 15 N 1 -Pro (Cambridge isotope laboratories) 200 mg / L, Ascorbic acid (Wako, trade name “L-ascorbic acid phosphate magnesium salt n hydrate”) 200 μM, Dialysis FBS (Thermo scientific, trade name) (Dialized FBS)) was cultured in a stable isotope-labeled DMEM containing 0.5% (manufactured by Thermo scientific, trade name “SILAC DMEM Media”) (100 mm dish). The medium was collected every 3 days and replaced with a medium having the above composition.
HCl was added to the culture supernatant obtained on the 3rd and 6th days after the start of the culture to make it 0.1N, and the agarose-immobilized pepsin (product of SIGMA, product) was made to be 0.1 mg / mL. The name “Pepsin-Agarose”) was added and digestion reaction was carried out at 4 ° C. for 16 hours. After the reaction, the mixture was centrifuged to separate agarose-immobilized pepsin, and a supernatant was obtained. NaCl was added to the supernatant so that the concentration became 1 M, and the mixture was allowed to stand on ice for 3 hours, and then centrifuged to collect a precipitate.
The separated precipitate was washed with 1M NaCl and 95% ethanol, and finally dissolved in 250 μl of 5 mM acetic acid was used as labeled collagen.

  The substitution rate of the stable isotope-labeled Pro and 4Hyp in the labeled collagen produced in 1 to 3 days and 4 to 6 days in culture was measured by the substitution rate measurement method described below. Labeled collagen was produced using 3 media. The result of the stable isotope labeled Pro substitution rate is shown in FIG. 1, and the result of the stable isotope labeled 4Hyp substitution rate is shown in FIG. In FIG. 1 and FIG. 2, the numerical value on the horizontal axis indicates the amount of stable isotope-labeled Pro added (mg / L). Moreover, the substitution rate of the stable isotope labeling Pro, 4Hyp, 3Hyp, Lys, Hyl, GHL, GGHL, and Arg of the labeled collagen produced in 4 to 6 days of culture was measured in the same manner. The results are shown in Table 1. As shown in Table 1, in the labeled collagen of Example 1, 90% or more of each of Pro, 4Hyp, 3Hyp, Lys, Hyl, GHL, GGHL, and Arg constituting the collagen was substituted.

(Example 2)
A labeled collagen was obtained in the same manner as in Example 1 except that Gln was further added to the medium of Example 1 so as to be 300 mg / L, and then the substitution rates of stable isotope-labeled Pro and 4Hyp were measured. The results are shown in FIGS.

(Example 3)
After obtaining labeled collagen in the same manner as in Example 1 except that the amount of ¹³ C ₅ ¹⁵ N ₁ -Pro added to the medium was changed from 200 mg / L to 50 mg / L, the substitution rate of stable isotope-labeled Pro and 4Hyp was obtained. Was measured. The results are shown in FIGS.

Example 4
A labeled collagen was obtained in the same manner as in Example 1 except that Gln was further added to the medium of Example 3 so as to be 300 mg / L, and then the substitution rates of stable isotope labeled Pro and 4Hyp were measured. The results are shown in FIGS.

(Example 5)
After obtaining labeled collagen in the same manner as in Example 1 except that the amount of ¹³ C ₅ ¹⁵ N ₁ -Pro added to the medium was changed from 200 mg / L to 350 mg / L, the substitution rate of stable isotope-labeled Pro and 4Hyp was obtained. Was measured. The results are shown in FIGS.

(Example 6)
A labeled collagen was obtained in the same manner as in Example 1 except that Gln was further added to the medium of Example 5 so as to be 300 mg / L, and then the substitution rates of stable isotope-labeled Pro and 4Hyp were measured. The results are shown in FIGS.

(result)
As shown in FIG. 1 and FIG. 2, when 200 mg / L of ¹³ C ₅ ¹⁵ N ₁ -Pro was added and Gln was not added, the substitution rate of Pro, 4Hyp with a labeled amino acid was excellent.

(Example 7)
The labeled collagen obtained in Example 1 was subjected to SDS-denatured polyacrylamide gel electrophoresis. The results are shown in FIG. It was found that collagen type I and collagen type III coexist. For reference, the amino acid sequences of human collagen α1 (I) and human collagen α2 (I) are shown in SEQ ID NO: 12 and SEQ ID NO: 13, respectively. This is registered in the US National Center for Biotechnology Information (NCBI) as SEQ ID NOs: NP — 000080.2, NP — 000080.2.

(Example 8)
Labeled collagen was prepared from the culture medium for 4 to 6 days or more in the same manner as in Example 1, and the total amount of collagen was quantified. After 80 μl of labeled collagen was concentrated by centrifugation, acid hydrolysis was performed under conditions of 6N HCl (gas) at 110 ° C. for 20 hours. This was dissolved in 20 mM HCl, and a half amount was analyzed with a high-speed amino acid analyzer L-8900 (Hitachi) using a cation exchange column and a ninhydrin-post column method, and the peak area of each amino acid was measured. The content of each amino acid was quantified from the ratio between the peak area and the peak area of a known amount of the sample, and the total was taken as the amount of labeled collagen. Table 2 shows the molar concentration and content of amino acids contained in the labeled collagen, and the number of residues per 1000 residues of each amino acid converted from the molar concentration. The collagen concentration of the labeled collagen by the total amino acid analysis was 209.3 μg / ml.

Example 9
The labeled collagen obtained in Example 8 was quantified by type.
To 40 μl of labeled collagen, 5 μg of human placenta-derived type I collagen and 5 μg of type III collagen were added, and to this, Tris-HCl (pH 7.6) and CaCl 2 were added so as to be 1 mM, and 60 ° C. Denaturation treatment was performed for 30 minutes. Then, trypsin (product name “Sequencing Grade Modified Trypsin, Frozen” manufactured by Promega Corporation) in an amount of 1/100 of the protein amount was added, and enzymatic degradation was performed at 37 ° C. for 16 hours. Formic acid was added to the obtained decomposition solution so as to be 1% to obtain an analysis solution.
About the said analysis liquid, the peak area was measured by LC / MS conditions of the peptide analysis of the term of the substitution rate measurement mentioned later. The peptides were peptides having the sequences GVQGPOGPAGPPR, GVVGLOGQR, EGPVGLOGIDGR, and GPSGPQGIR contained in collagen type α1 chain and collagen type α2 chain. Table 3 shows MRM (Multiple Reaction Monitoring) channels of these peptides in LC / MS analysis. For each peptide, the peak area ratio of the labeled collagen constituting peptide to the human placenta-derived type I collagen constituting peptide was determined. The average of the peak area ratio of the above 4 peptides, 2 channels each, and a total of 8 channels was calculated and multiplied by 5 μg as the amount of human placenta-derived type I collagen to obtain 1.394 × (5 (μg) / 40 (μl)) × The concentration of labeled collagen type I contained in the labeled collagen was calculated from 1000 = 174.3 (μg / ml). The results are shown in Table 4.

  In the same manner as described above, the peak area ratio of the labeled collagen-derived labeled peptide to the human placenta-derived type III collagen-constituting peptide was determined using the peptide sequences GLAGPOGMMOGPR and GROLOGAGAAR contained in the collagen type III α1 chain as indices. The average of the peak area ratios measured for the above 2 peptides, 2 channels each, and a total of 4 channels was calculated and multiplied by 5 μg as the amount of human placenta-derived type III collagen to give 0.153 × (5 (μg) / 40 (μl) ) × 1000 = 19.1 (μg / ml), the concentration of labeled collagen type III contained in the labeled collagen was calculated. The results are shown in Table 4. The labeled collagen obtained in Example 8 contained 174.3 μg / ml labeled collagen type I and 19.1 μg / ml labeled collagen type III.

(Example 10)
The total collagen amount quantification (Example 10) and the type-specific collagen quantification (Example 11) of collagen extracted from rat skin using the labeled collagen prepared in Example 8 (hereinafter also referred to as rat skin collagen) were performed, The quantitative accuracy was confirmed. First, the concentration of rat skin collagen as a measurement object was calculated from the total amount of amino acids, and 20 μl of labeled collagen prepared in Example 8 was added to the theoretical amount of 20 μg to obtain a measurement sample. 9/10 volume was used as a sample for type-specific collagen quantification described later, and the remaining measurement sample was dried to dryness by centrifugal concentration, followed by acid hydrolysis for 20 hours under conditions of 6N HCl (gas) and 110 ° C. It was. The acid hydrolyzate was dissolved in a solution obtained by adding 50% acetonitrile to 0.1% acetic acid and ammonium acetate to 5 mM, and amino acid analysis in the method of measuring the substitution rate described later The analysis was performed under the LC / MS conditions.

  Two rats were used and the peak area ratio of rat skin collagen-derived 4Hyp to labeled collagen-derived 4Hyp was measured using 4Hyp unique to collagen as an index. The average peak area ratio was 5.14. The collagen content of the labeled collagen used for the measurement sample is 209.3 (μg / ml) from Example 8. Therefore, the labeled collagen contained in the measurement sample is 209.3 (μg / ml) × 20 (μl). The amount of rat skin collagen contained in the measurement sample was calculated to be 5.14 × 0.2093 (μg / μl) × 20 (μl) = 21.5 (μg) by multiplying this by the previous mass ratio. The value was very close to the collagen amount of 20 μg calculated from the total amino acid amount, and its quantitative accuracy was confirmed. Table 5 shows the results of quantification of the total collagen concentration of rat skin collagen.

(Example 11)
Using the labeled collagen prepared in Example 8, the type-specific collagen concentration of rat skin collagen analyzed in Example 10 was measured. Tris-HCl (pH 7.6) and 1 mM so that it becomes 100 mM in 9/10 of the measurement sample obtained by adding 20 μl of labeled collagen prepared in Example 8 to 20 μg of rat skin collagen used in Example 10. CaCl2 was added and a denaturation treatment was performed at 60 ° C. for 30 minutes. Then, trypsin (product name “Sequencing Grade Modified Trypsin, Frozen” manufactured by Promega Corporation) in an amount of 1/100 of the protein amount was added, and enzymatic degradation was performed at 37 ° C. for 16 hours. Formic acid was added to the obtained decomposition solution so as to be 1% to obtain an analysis solution.

  This analysis solution was analyzed under the LC / MS conditions of peptide analysis in the section of substitution rate measurement described later. The peak area of rat skin collagen type I-derived peptide relative to the peak area of labeled collagen type I-derived peptide for 4 peptides, 2 channels each, and a total of 8 channels contained in collagen type I α1 chain and collagen type α2 chain shown in Table 3 The ratio was measured. Two rats were used, and the average peak area ratio of the measured values was 4.96. Further, in the same manner as described above, rat skin collagen type III-derived peptide with respect to the peak area of labeled collagen type III-derived peptide with 2 channels each for a total of 4 channels for 2 peptides contained in collagen type III α1 chain shown in Table 3 The peak area ratio was measured. Two rats were used, and the average peak area ratio was 12.98.

  As shown in Example 9, the labeled collagen contains 174.3 μg / ml collagen type I and 19.1 μg / ml collagen type III. Since the peak area ratio of the target collagen-derived type I peptide to the labeled collagen-derived type I peptide is 4.96, the amount of target collagen contained in the measurement sample is 4.96 × 0.1743 (μg / μl) × It was quantified as 20 (μl) = 17.3 (μg). Similarly, type III was quantified as 12.98 × 0.0191 (μg / μl) × 20 (μl) = 5.0 μg, and the total of type I and type III collagen was 22.3 μg. The value was very close to the collagen amount of 20 μg calculated from the total amino acid amount, and its quantitative accuracy was confirmed. The results are shown in Table 5.

(Example 12)
For collagen extracted from rat bone and collagen extracted from rat tail tendon instead of rat skin collagen, the total collagen amount and type-specific collagen amount were quantified in the same manner as in Example 10 and Example 11. The results are shown in Table 5. The total collagen quantification and type-specific collagen quantification in each tissue-derived collagen showed a result that the calculated collagen amount was very close to the collagen amount of 20 μg defined by the total amino acid amount, and the quantitative accuracy was confirmed. FIG. 4 shows the mixing ratio of type I and type III collagen derived from rat skin, bone, and tail tendon.

(Example 13)
Labeled collagen was prepared by combining equal amounts of the labeled collagen derived from the 3 culture medium 4 to 6 days obtained in Example 1 with each other. Using this, collagen extracted from rat skin, bone, and tail tendon was used as the collagen to be measured, the post-translational modified amino acid concentration was quantified, and the number of each amino acid residue per 1000 amino acid residues was quantified.

  Collagen was collected from rat skin, bone and tail tendon. 10 μl of labeled collagen was added to 10 μg of each sample, and 1/10 of this was fractioned to obtain a measurement sample. This measurement sample was dried to dryness by centrifugal concentration, and then acid hydrolysis was performed under conditions of 6N HCl (gas) at 110 ° C. for 20 hours. In the method for measuring the substitution rate described below, the solid solution obtained by acid hydrolysis is dissolved in a solution obtained by adding ammonium acetate to 50 mM acetonitrile so that acetic acid is 0.1% and 5 mM. Based on LC / MS conditions for amino acid analysis, the mass ratio of Pro, 3Hyp, 4Hyp, Lys, Hyl, and Arg to the target collagen constituent amino acid with respect to the labeled collagen constituent amino acid was measured based on the peak area.

  Moreover, the sodium hydroxide solution was added so that it might become 2N to the remaining 9/10 quantity of the said measurement sample, and the alkali hydrolysis was performed at 110 degreeC for 20 hours. The obtained alkaline hydrolyzate was neutralized with cold 30% acetic acid, desalted with a cation exchange column (Waters, trade name “OASIS MCX”), and the eluate was dried by centrifugal concentration. The amino acid in the method for measuring the substitution rate described below is dissolved in a solution obtained by adding ammonium acetate to 5 mM so that acetic acid is 0.1% in 50% acetonitrile. Under the LC / MS conditions of the analysis, the mass ratio of Hyl, GHL, and GGHL to the measurement target collagen constituent amino acid with respect to the labeled collagen constituent amino acid was measured.

  Collagen derived from rat skin, bone, and tail tendon uses collagen extracted from three rats, respectively, and the mass ratio is an average value of three individuals. The mass ratio of the target collagen-derived Pro to the labeled collagen-derived Pro in skin collagen was 7.402, and the same mass ratio of Arg was 7.766. The mass ratio of Arg corresponds to the amount of rat skin collagen relative to the amount of labeled collagen. Therefore, the Pro mass ratio per mole of rat skin collagen is 7.402 / 7.766. Since the number of residues per 1000 amino acid residues of the stable isotope-labeled Pro constituting the labeled collagen is 104.8 from Table 1, the number of Pro residues per 1000 amino acid residues in rat skin collagen is (7 .402 / 7.776) × 104.8 = 99.9. Similarly, the number of residues per 1000 amino acid residues of Pro, 3Hyp, 4Hyp, Lys, Hyl, GHL and GGHL of collagen extracted from rat skin, bone and tail tendon was measured. These results and literature values are shown in Table 6. In Table 6, Hyl is a measured Hyl value of the alkali hydrolysis sample. Moreover, total Hyl is the sum of Hyl, GHL, and GGHL from which sugar chains are removed, and is a measured Hyl value of a hydrochloric acid-hydrolyzed sample. This is because, in acid hydrolysis, GHL and GGHL sugar chains are removed and become Hyl.

(Example 14)
Using the labeled collagen prepared in Example 13, the relative ratio of amino acids constituting collagen extracted from rat skin, bone, and tail tendon was analyzed.
First, collagen was collected from rat skin, bone, and tail tendon. 10 μl of the labeled collagen prepared in Example 13 was added to 10 μg of each sample, and 1/10 of the amount was fractioned to obtain a measurement sample. This measurement sample was dried to dryness by centrifugal concentration, and then acid hydrolysis was performed under conditions of 6N HCl (gas) at 110 ° C. for 20 hours. Moreover, the sodium hydroxide solution was added so that it might become 2N to the remaining 9/10 quantity of the said measurement sample, and the alkali hydrolysis was performed at 110 degreeC for 20 hours. The obtained alkaline hydrolyzate was neutralized with cold 30% acetic acid, desalted with a cation exchange column (Waters, product “OASIS MCX”), and the eluate was dried by centrifugal concentration.

  The acid hydrolyzate and the dried product obtained by alkali hydrolysis were dissolved in a solution obtained by adding 50% acetonitrile to 0.1% acetic acid and 5 mM ammonium acetate to be described later. In the LC / MS conditions for amino acid analysis in the method for measuring the substitution rate, the mass ratio of the collagen-derived component to be measured to the labeled collagen-derived component for Pro, 3Hyp, 4Hyp, Lys, Hyl, GHL, GGHL and Arg of each measurement sample (Measurement target collagen constituting amino acid / labeled collagen constituting amino acid) (hereinafter also referred to as AMI mass ratio) was measured. Next, for each measurement sample, the mass ratio of the collagen to be measured derived Arg to the labeled collagen derived Arg (hereinafter also referred to as Arg mass ratio) is obtained, and the AMI mass ratio (AMI mass ratio / Arg mass) with respect to the Arg mass ratio for each amino acid. Ratio). In addition, the collagen derived from rat skin, bone, and tail tendon uses collagen extracted from three rats, respectively, and the mass ratio is an average value of three individuals.

  The bone collagen-derived component and the tail tendon collagen-derived component (AMI mass ratio / Arg mass ratio) relative to the rat skin collagen-derived component (AMI mass ratio / Arg mass ratio) were determined as percentages. The results are shown in Table 7 and FIG. In Table 7 and FIG. 5, Hyl is the measured Hyl value of the alkali-hydrolyzed sample, total Hyl is the sum of the Hyl, GHL and GGHL sugar chains, and the measured Hyl value of the hydrochloric acid-hydrolyzed sample. It is.

  As shown in Table 7 and FIG. 5, the tail tendon-derived collagen has a feature that the amount of 3Hyp is as high as 441% compared to 3Hyp derived from the skin, while GHL is low at 33.9% and GGHL is low at 21.6%. It was clearly detected. As shown in Table 6, the characteristics shown in Table 7 and FIG. 5 corresponded to the values of Non-Patent Document 5 with respect to the 3Hyp value, and the GHL and GGHL values matched the values of Non-Patent Document 6.

(Example 15)
Using the labeled collagen prepared in Example 13, changes over time in the amount of 4Hyp due to acid hydrolysis of rat skin collagen were measured.
1 μl of labeled collagen prepared in Example 13 was added to 1 μg of rat skin collagen to prepare a measurement sample. This measurement sample was dried by centrifugal concentration, and then subjected to acid hydrolysis under conditions of 6N HCl (gas) and 110 ° C. for 1 hour. This acid hydrolyzate was dissolved in a solution obtained by adding 50% acetonitrile to acetic acid to 0.1% and ammonium acetate to 5 mM, and the LC of amino acid analysis described in the measurement conditions for the substitution rate was used. Under the / MS condition, the peak area of labeled collagen-derived 4Hyp, the peak area of measured collagen-derived 4Hyp, and the peak area ratio of measured collagen-derived 4Hyp to labeled collagen-derived 4Hyp were measured. The same operation was performed on the measurement samples at 2, 4, 8, 16, and 24 hours after hydrolysis.

The percentage of the peak area ratio at 2, 4, 8, 16, and 24 hours after hydrolysis with respect to the peak area ratio of non-labeled 4Hyp / labeled 4Hyp to the measurement target collagen-derived 4Hyp after 1 hour of hydrolysis Calculated. The results are shown in the bar graph of FIG.
On the other hand, the percentage of the peak area of the measurement target collagen-derived 4Hyp at 2, 4, 8, 16, and 24 hours after hydrolysis with respect to the peak area (non-labeled 4Hyp) of the measurement target collagen-derived 4Hyp for 1 hour of hydrolysis was calculated. The results are shown in the line graph of FIG. In the same manner, Hyl, a post-translationally modified amino acid of Lys, was also measured.

As shown in the line graph of FIG. 6, it was shown that the measurement target collagen-derived 4Hyp increases with time after hydrolysis for 2 hours with the progress of hydrolysis. As shown in the bar graph of FIG. 6, the peak area ratio of the measurement target collagen-derived 4Hyp to the labeled collagen-derived labeled 4Hyp was in the range of 94.8 to 100% and was substantially uniform. It was shown that the labeled collagen and the collagen to be measured are hydrolyzed to the same extent. Changes in the collagen-derived Hyl to be measured with each hydrolysis process and the peak area ratio of the collagen-derived Hyl to be measured relative to the labeled collagen-derived Hyl also showed the same tendency as the 4Hyp described above (not shown).
As shown in FIG. 6, since the peak area ratio is substantially the same at any stage of hydrolysis, collagen is quantified by multiplying the mass of labeled collagen added to the peak area ratio after 1 hour of hydrolysis. And the quantification time can be shortened.

(Example 16)
The influence of components other than collagen contained in the measurement sample on the measurement value was evaluated.
Dilute PBS solution (SIGMA, trade name “Dulbecco's Phosphate Buffered Saline”), and add 0 × PBS, 0.1 × PBS, 0.2 × PBS, 0.5 × PBS, 1 × PBS solution. 4 Hyp preparation (trade name “trans-4-Hydroxy-L-proline”, manufactured by SIGMA) was added to each 0.5 nmol, and 4 μl of the labeled collagen prepared in Example 13 was previously subjected to acid hydrolysis. 1/50 amount of the sample was added to each measurement sample. This was subjected to LC / MS analysis under the following conditions, the peak areas of labeled collagen-derived labeled 4Hyp and 4Hyp samples were measured, and the peak area ratio of 4Hyp sample to labeled collagen-derived labeled 4Hyp was calculated. The peak area ratio of the PBS-added sample when the peak area ratio without adding PBS is 100% is shown in the bar graph of FIG.
Moreover, the peak area of each measurement sample of the 4Hyp standard sample of the PBS addition sample when the 4Hyp standard peak area of the system without PBS is 100% is shown in the line graph of FIG.

  As shown in the bar graph of FIG. 7, the peak area ratio of the 4Hyp sample to the labeled collagen-derived labeled 4Hyp was substantially constant at 99.2 to 105.9% between the measurement samples. On the other hand, as shown in the line graph of FIG. 7, the 4Hyp peak area value increases as the concentration of PBS contained as a contaminant increases in each system, as shown in the line graph in FIG. Fell sharply. That is, the peak area of the measurement target substance is easily affected by the measurement component depending on the component contained in the measurement sample, but the mass ratio between the measurement target collagen-derived component and the labeled collagen-derived component can offset this effect. It has been shown.

LC / MS analysis measurement conditions High performance liquid chromatograph: 1200Series (Agilent Technologies),
Mass spectrometer: 3200QTRAP (AB Sciex),
Analytical column: Discovery HS F5 5μm, 4.6mmi.d. × 250mm (SUPELCO),
Column temperature: 25 ° C
Mobile phase: Liquid A; 0.1% formic acid, Liquid B; 100% acetonitrile,
Gradient condition:
0 to 7.5 minutes: Liquid A 98%; Liquid B 2%,
7.5-20 minutes: Liquid A 98-10%; Liquid B 2-90%,
20.1-25 minutes: Liquid A 10%; Liquid B 90%
25.1-30 minutes: Liquid A 98%; Liquid B 2%,
Flow rate: 0.6 mL / min,
Mass spectrometry conditions:
Ionization: ESI, positive,
Analysis mode: Multiple Reaction Monitoring (MRM) mode,
Ion spray voltage: 3 kV
Ion source temperature: 600 ° C

(Example 17)
Quantification of blood free 4Hyp, peptide 4Hyp and total 4Hyp after ingestion of collagen peptide was performed.
(1) 100 ml of water in which 25 g of fish scale-derived collagen peptide powder is dissolved is orally ingested by a healthy person on an empty stomach, before ingestion (0 minutes), 30 minutes, 60 minutes, 120 minutes, 240 minutes, and 360 minutes after ingestion. Blood was collected. The collected blood was heparinized to prepare plasma and stored at −80 ° C. until analysis.
(2) 50 μl of labeled collagen prepared in Example 13 was hydrolyzed under conditions of 6N HCl (gas), 110 ° C., 20 hours, and dissolved in 1000 μl of distilled water to prepare a labeled collagen acid hydrolysis solution. 10 μl of this solution was added to 20 μl of plasma and 90 μl of ethanol was added. The mixture was then centrifuged and the supernatant was collected. 10 μl of the obtained supernatant was added to 190 μl of a measurement solvent containing 0.1% formic acid in 50% acetonitrile to obtain a free 4Hyp measurement sample. On the other hand, 50 μl of the supernatant was centrifugally concentrated to dryness, acid hydrolysis was performed under conditions of 6N HCl (gas), 110 ° C., 20 hours, and the obtained hydrolyzate was dissolved in 200 μl of the measurement solvent, All 4Hyp measurement samples were used. Furthermore, 1 μl of the labeled collagen acid hydrolysis solution was added to 100 μl of a solution containing 0.01, 0.1, 1 and 10 nmol / mL of 4Hyp samples, respectively, and used as a calibration curve sample. For each of these measurement samples and calibration curve samples, the peak areas of the measurement target plasma-derived 4Hyp, the labeled collagen-derived label 4Hyp, and the sample 4Hyp were measured under the LC / MS conditions described in the section on the method for measuring the substitution rate described later. .

  Based on the sample for the calibration curve, a calibration curve showing the relationship between the 4Hyp standard peak area / labeled 4Hyp peak area ratio and the 4Hyp concentration was prepared. The unlabeled 4Hyp peak area / labeled 4Hyp peak area ratio of the free 4Hyp measurement sample was converted with the calibration curve to determine the free 4Hyp concentration. Similarly, the total 4Hyp concentration was determined from the ratio of unlabeled 4Hyp peak area / labeled 4Hyp peak area contained in all 4Hyp measurement samples, and the difference between the total 4Hyp concentration and the free 4Hyp concentration was defined as the 4Hyp-containing peptide concentration. FIG. 8 shows changes with time of each concentration of free 4Hyp, total 4Hyp, and 4Hyp-containing peptides per plasma fluid volume after collagen peptide ingestion.

  On the other hand, for comparison, a calibration curve showing the relationship between the 4Hyp standard peak area and the 4Hyp concentration was created based on the calibration curve sample. The peak area of unlabeled 4Hyp of the free 4Hyp measurement sample was converted with the calibration curve to determine the free 4Hyp concentration. Similarly, the total 4Hyp concentration was determined from the peak area of unlabeled 4Hyp of all 4Hyp measurement samples, and the difference between the total 4Hyp concentration and the free 4Hyp concentration was defined as the 4Hyp-containing peptide concentration. FIG. 9 shows the time-dependent changes in the concentrations of free 4Hyp, total 4Hyp, and 4Hyp-containing peptides per plasma fluid volume after intake of collagen peptide.

  As shown in FIG. 9, when the mass ratio of 4Hyp derived from labeled collagen and 4Hyp derived from plasma to be measured was not used, there was a case where the amount of 4Hyp contained in the measurement sample was calculated as 0 or less. This is because various matrix components present in the blood affect ionization during the LC / MS measurement and cause measurement errors. However, as shown in FIG. 8, when 4Hyp is calculated based on the unlabeled 4Hyp / labeled 4Hyp mass ratio, the measurement error due to the matrix component is offset, no measured value of 0 or less exists, and the quantitative value is about 2 It has been shown that it can be doubled to correct significant ionization suppression.

(3) Ammonium bicarbonate was added to 150 μl of labeled collagen prepared in Example 13 to 100 mM, and trypsin (product name “Trypsin from bovine pancreas”, manufactured by SIGMA) of 1/20 of the protein amount was added. The enzymatic degradation was performed at 37 ° C. for 16 hours. After heating at 100 ° C. for 5 minutes to inactivate trypsin and drying to dryness by centrifugal concentration, 50 μl of dialysis FBS was added and reacted at 37 ° C. for 24 hours. To this was added 150 μl of ethanol, and the mixture was centrifuged. The supernatant was dried by centrifugation and then dissolved in 100 μl of distilled water to obtain a stable isotope-labeled oligopeptide solution.
To 10 μl of each plasma obtained in (1) above, 10 μl of a stable isotope-labeled oligopeptide solution was added, and 60 μl of ethanol was added, followed by centrifugation to obtain a supernatant. 60 μl of this supernatant was dried by centrifugal concentration, and then dissolved in 50 μl of 1% formic acid to obtain an oligopeptide measurement sample.
Also, 4 μl of the stable isotope-labeled oligopeptide solution is added to 50 μl of 0.1, 0.2, 0.5 and 1 nmol / mL solutions of synthetic oligopeptides ProHyp, GluHyp, LeuHyp, PheHyp, GlyProHyp, AlaHypGly, ProHypGly and SerHypGly. And used as a calibration curve sample. With respect to these measurement samples and calibration curve samples, the peak areas of the measurement target plasma-derived oligopeptide, stable isotope-labeled oligopeptide, and synthetic oligopeptide were measured under the following LC / MS analysis conditions.

  Based on the calibration curve sample, a calibration curve showing the relationship between the ratio of the synthetic oligopeptide peak area / labeled oligopeptide peak area and the oligopeptide concentration was prepared. The concentration of each oligopeptide was determined by converting the unlabeled oligopeptide peak area ratio / labeled oligopeptide peak area ratio of the measurement sample using the calibration curve. FIG. 10 shows the change over time in the concentration of each oligopeptide per plasma fluid volume after collagen peptide ingestion. In addition, the value of 4Hyp containing peptide total amount was computed by said (2), and used what was shown in FIG.

  By using the enzyme degradation product of labeled collagen of Example 13 as an internal standard, it was possible to eliminate the influence of the contained matrix component and obtain an accurate measurement value. Actually, as shown in FIG. 10, the values of the total amount of the 8 peptides obtained in the above (3) and the total amount of the 4Hyp-containing peptide obtained in the above (2) agreed very well.

(4) LC / MS analysis measurement conditions High-performance liquid chromatograph: 1200Series (Agilent Technologies),
Mass spectrometer: 3200QTRAP (AB Sciex),
Analytical column: Synergi Hydro-RP 4μm, 2.0mmi.d. × 250mm (Phenomenex),
Column temperature: 40 ° C
Mobile phase: Liquid A; 0.1% formic acid, Liquid B; 100% acetonitrile,
Gradient condition:
0 to 7.5 minutes: Solution A 100%; Solution B 0%,
7.5-20 minutes: Liquid A 100-50%; Liquid B 0-50%,
20.1-25 minutes: A liquid 20%; B liquid 80%,
25.1-30 minutes: Liquid A 100%; Liquid B 0%,
Flow rate: 0.25 mL / min,
Mass spectrometry conditions:
Ionization: ESI, positive,
Analysis mode: MRM mode,
Ion spray voltage: 4 kV
Ion source temperature: 700 ° C

(Example 18)
According to Non-Patent Document 4, HEL cells 2 × 10 4 cells dispersed in DMEM (manufactured by SIGMA) each containing 10% FBS (manufactured by Intergen) were seeded in 3 wells of a 48-well plate, and 20 mM HEPES, 15 mg, after one night. The assay buffer was replaced with 150 μl of DMEM containing / mL BSA and incubated for 30 minutes. To the first well, 0.75 μg of the labeled collagen prepared in Example 13 was added and further incubated for 5 hours.
In the second well, 10 μM of a lysosomal cysteine protease inhibitor (E-64d manufactured by Merck Millipore) was added and incubated for 30 minutes in order to suppress degradation of collagen taken in thereafter, and then labeled in the same manner as in the first well. 0.75 μg of collagen was added and further incubated for 5 hours.
The third well was incubated for 5 hours as above without adding labeled collagen as a control.
Each cell was collected using trypsin (trade name “Trypsin-EDTA solution” manufactured by SIGMA), dried by centrifugal concentration, and then acidified under conditions of 6N HCl (gas) at 110 ° C. for 20 hours. Hydrolysis was performed. The obtained hydrolyzate was dissolved in a solution obtained by adding ammonium acetate to 50% acetonitrile to 0.1% acetic acid and 5 mM, and the LC / MS analysis described in the substitution rate measurement method was performed. The amount of labeled collagen-derived 4Hyp was measured under amino acid measurement conditions. 0.75 μg of labeled collagen was hydrolyzed with hydrochloric acid in the same manner as described above, and the peak area of labeled collagen-derived 4Hyp was measured. The percentage of the measured value relative to this value was calculated and used as the uptake rate. The results are shown in FIG. It was observed that the amount of labeled collagen-derived labeled 4Hyp in the cells was increased by adding a lysosomal cysteine protease inhibitor (E-64d) to the medium.

(Example 19)
Labeled collagen II substituted with stable isotope labeled Pro was produced by the following method.

RCS cells 1.5 × 10 ⁶ cells were prepared using Lys (manufactured by Thermo scientific) 100 mg / L, Arg (manufactured by Thermo scientific) 100 mg / L, ¹³ C ₅ ¹⁵ N ₁ -Pro (manufactured by Cambridge isotope Laboratories / 200 mg). L, ascorbic acid (Wako, trade name “L-ascorbic acid phosphate magnesium salt n hydrate”) 200 μM, dialysis FBS (Thermo scientific, trade name “Dialized FBS”) 10% The culture was performed with DMEM for isotope labeling (product name “SILAC DMEM Media”, manufactured by Thermo scientific) (100 mm dish). The medium was replaced every 3 days with the medium having the above composition.
0.1 mg / mL pepsin (manufactured by SIGMA) (0.1N HCl) was added to cells and deposited collagen on the medium, and digestion reaction was performed at 4 ° C. for 16 hours. NaCl was added to this pepsin digestion solution so that it might become 2M, and it left still on ice for 3 hours, and then centrifuged. The precipitate was washed with 2M NaCl and 95% ethanol, and finally dissolved with 5 mM acetic acid to obtain labeled collagen II.

(Example 20)
The labeled collagen II obtained in Example 19 was subjected to SDS-denatured polyacrylamide gel electrophoresis. The results are shown in FIG. It was found that collagen type II, collagen type IX and collagen type XI are mixed.

(Measurement method of substitution rate of labeled amino acid / labeled peptide)
In the present invention, the substitution rate of labeled amino acids and labeled peptides in labeled collagen was measured according to the following method. When the measurement target was a peptide, the mass ratio of the labeled collagen constituting peptide and the measurement target collagen constituting peptide was measured by the following method.
(1) Preparation of sample (i) Measurement method of substitution rate of stable isotope-labeled Pro, 3Hyp, 4Hyp, Lys, Hyl and Arg by acid hydrolysis 10 μl of labeled collagen dissolved in 5 mM acetic acid was dried by centrifugation. Thereafter, hydrolysis was carried out at 6N HCl (gas) at a temperature of 110 ° C. for 20 hours. This hydrochloric acid hydrolyzate was dissolved in a solution obtained by adding 50% acetonitrile to acetic acid to 0.1% and ammonium acetate to 5 mM, and mass spectrometry was performed under the following LC / MS analysis measurement conditions. The peak area of each amino acid was measured. Based on the peak area, the percentage of labeled amino acids relative to the sum of labeled amino acids and unlabeled amino acids (labeled amino acids × 100 / (labeled amino acids + unlabeled amino acids)) was calculated and used as the substitution rate (mol%) of labeled amino acids. The substitution rate of Pro, 3Hyp, 4Hyp, Lys, Hyl and Arg was calculated from the acid hydrolysis sample. In addition, since Hyl includes Hyl from which the sugar chains of GHL and GGHL are removed, the value is the total Hyl including these.
(Ii) Method for measuring the substitution rate of stable isotope-labeled Hyl, GHL and GGHL by alkaline hydrolysis Sodium hydroxide was added to 50 μl of labeled collagen dissolved in 5 mM acetic acid to replace 2N with 6N HCl (gas) Thereafter, hydrolysis was performed in the same manner as described above. The obtained alkaline hydrolyzate was neutralized with cold 30% acetic acid, desalted with a cation exchange column (Waters, trade name “OASIS MCX”), and the eluate was dried by centrifugal concentration. Dissolve in 50% acetonitrile in 0.1% acetic acid and 5 mM ammonium acetate in a solution and perform mass spectrometry under the following LC / MS analysis measurement conditions. The substitution rate (mol%) was calculated based on The substitution rate of GHL and GGHL was calculated from the alkaline hydrolysis sample.
(Iii) Measuring method of substitution rate of stable isotope-labeled peptide To labeled collagen dissolved in 5 mM acetic acid and collagen to be measured, trypsin (product name “Sequencing Grade Modified Trypsin, Frozen, manufactured by Promega, Inc.) of 1/100 of the protein amount. ”) Was added, and enzymatic degradation was performed at 37 ° C. for 16 hours. After adding formic acid to the obtained decomposition solution so as to be 1%, the peak area of the peptide was measured under the following LC / MS analysis measurement conditions.

(2) LC / MS analysis measurement conditions (i) Amino acid analysis High performance liquid chromatograph: 1200Series (Agilent Technologies),
Mass spectrometer: 3200QTRAP (AB Sciex),
Analytical column: ZIC-HILIC 3.5μm, 2.1mmi.d. × 150mm (Merck SeQuant),
Column temperature: 25 ° C
Mobile phase: Solution A; 0.1% acetic acid, 5 mM ammonium acetate, Solution B; 100% acetonitrile,
Gradient condition:
0 to 5 minutes: Liquid A 10%; Liquid B 90%
5-20 minutes: Liquid A 10-95%; Liquid B 90-5%,
20-25 minutes: Solution A 95%; Solution B 5%,
25.1-30 minutes: Liquid A 10%; Liquid B 90%
Flow rate: 0.2 mL / min,
Mass spectrometry conditions:
Ionization: ESI, positive,
Analysis mode: MRM mode,
Ion spray voltage: 3 kV
Ion source temperature: 600 ° C

(Ii) Peptide analysis High-performance liquid chromatograph: 1200Series (Agilent Technologies),
Mass spectrometer: 3200QTRAP (AB Sciex),
Analytical column: Ascentis Express C18 5μm, 2.1mmi.d. × 150mm (SUPELCO),
Column temperature: 25 ° C
Mobile phase: Liquid A; 0.1% formic acid, Liquid B; 100% acetonitrile,
Gradient condition:
0-2 minutes: Liquid A 98%; Liquid B 2%,
2.1-6 minutes: A liquid 98-40%; B liquid 2-60%,
6.1-8 minutes: Liquid A 10%; Liquid B 90%
8.1-10 minutes: Liquid A 98%; Liquid B 2%
Flow rate: 0.5 mL / min,
Mass spectrometry conditions:
Ionization: ESI, positive,
Analysis mode: (MRM) mode,
Ion spray voltage: 4 kV
Ion source temperature: 700 ° C

  According to the present invention, stable isotope-labeled collagen can be used to quantify the post-translationally modified amino acid amount, total collagen amount, type-by-type collagen amount, etc. of collagen for diagnosis, evaluation of drug efficacy, etc. It can be used and is useful.

Claims (5)

  At least one amino acid selected from the group consisting of Pro, Lys, Arg, Leu, Met, Phe, Thr, Val, Ile and His constituting collagen is substituted by 90 mol% or more with the corresponding stable isotope-labeled amino acid. A stable isotope-labeled collagen obtained by post-translationally modifying a stable isotope-labeled collagen precursor.   The stable isotope-labeled collagen according to claim 1, wherein the stable isotope-labeled collagen precursor is obtained by replacing at least Pro, Lys and Arg with 90 mol% or more of the corresponding stable isotope-labeled amino acid.   The stable isotope-labeled collagen according to claim 1 or 2, wherein Hyp is substituted by 90 mol% or more with a corresponding stable isotope-labeled amino acid.   The stable isotope labeled collagen according to any one of claims 1 to 3, wherein the substitution is 95 mol% or more.   An amino acid composition or a peptide composition obtained by degrading the stable isotope-labeled collagen according to any one of claims 1 to 4.